Status:
UNKNOWN
Effect of Fully Blocking Type 1 Angiotensin Receptor on Target Organ Damage of Postmenopausal Hypertensive Women
Lead Sponsor:
LanZhou University
Conditions:
Hypertension
Eligibility:
All Genders
40-65 years
Phase:
NA
Brief Summary
This study compared the improvements of blood pressure levels, left ventricular hypertrophy, left ventricular diastolic function, vascular function and cognitive function between postmenopausal hypert...
Eligibility Criteria
Inclusion
- Clinical diagnosis of hypertension
- Women are all postmenopausal
- Must provide written informed consent
Exclusion
- Secondary hypertension
- Coronary disease
- Heart failure
- Arterial fibrillation
- Previous myocardial infarction
- Previous stroke
- Malignant disease
- Kidney failure
- Liver failure
- Neoplastic disease
- Severe neurological diseases
- Severe metabolic or organic decompensation
- Refuse to sign the informed consent form
Key Trial Info
Start Date :
April 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2019
Estimated Enrollment :
102 Patients enrolled
Trial Details
Trial ID
NCT03432468
Start Date
April 1 2018
End Date
August 1 2019
Last Update
March 13 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.